摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,3-O-isopropylidene 5-O-tert-butyldimethylsilyl L-Lyxono-1,4-lactone | 1044813-00-4

中文名称
——
中文别名
——
英文名称
2,3-O-isopropylidene 5-O-tert-butyldimethylsilyl L-Lyxono-1,4-lactone
英文别名
(3aR,6S,6aR)-6-(((tert-butyldimethylsilyl)oxy)methyl)-2,2-dimethyldihydrofuro[3,4-d][1,3]dioxol-4(3aH)-one;(3aR,6S,6aR)-6-[[tert-butyl(dimethyl)silyl]oxymethyl]-2,2-dimethyl-6,6a-dihydro-3aH-furo[3,4-d][1,3]dioxol-4-one
2,3-O-isopropylidene 5-O-tert-butyldimethylsilyl L-Lyxono-1,4-lactone化学式
CAS
1044813-00-4
化学式
C14H26O5Si
mdl
——
分子量
302.443
InChiKey
VBPYRQYBEKHPKA-HBNTYKKESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    371.0±42.0 °C(Predicted)
  • 密度:
    1.031

计算性质

  • 辛醇/水分配系数(LogP):
    2.45
  • 重原子数:
    20
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.93
  • 拓扑面积:
    54
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • One-Pot Tandem Strecker Reaction and Iminocyclisations: Syntheses of Trihydroxypiperidine α-Iminonitriles
    作者:Benjamin J. Ayers、George W. J. Fleet
    DOI:10.1002/ejoc.201301705
    日期:2014.4
    Unbranched, and α- and β-methyl-branched, trihydroxypiperidine α-iminonitriles have been obtained in a single step from protected 5-O-tosylate pentoses. This reaction comprises a one-pot tandem Strecker reaction and iminocyclisation. These trihydroxypiperidine α-iminonitriles are precursors to trihydroxypipecolic acids. No formation of pyrrolidine products was observed.
    从受保护的 5-O-甲苯磺酸戊糖中一步即可获得未支化和 α- 和 β- 甲基支化的三羟基哌啶 α-亚基腈。该反应包括一锅串联 Strecker 反应和亚胺环化反应。这些三羟基哌啶α-亚基腈是三羟基哌啶酸的前体。没有观察到吡咯烷产物的形成。
  • [EN] RIBONUCLEIC ACIDs WITH 4'-THIO-MODIFIED NUCLEOTIDES AND RELATED METHODS<br/>[FR] ACIDES RIBONUCLÉIQUES AYANT DES NUCLÉOTIDES 4'-THIO-MODIFIÉS ET PROCÉDÉS ASSOCIÉS
    申请人:SHIRE HUMAN GENETIC THERAPIES
    公开号:WO2014152513A1
    公开(公告)日:2014-09-25
    Disclosed are messenger RNA molecules and related compositions incorporating a 4'-thio modification in the furanose ring of at least one nucleotide residue, and methods of using these mRNAs to produce an encoded therapeutic protein invivo and to treat or prevent diseases or disorders. In certain embodiments, the 4'-thio modified mRNA provides for enhanced stability and/or reduced immunogenicity in in vivo therapies.
    本文揭示了信使RNA分子及相关组合物,其中至少一个核苷酸残基的呋喃糖环中包含4'-代修饰,并且使用这些mRNA来在体内产生编码的治疗蛋白质并用于治疗或预防疾病或紊乱的方法。在某些实施例中,4'-代修饰的mRNA在体内疗法中提供了增强的稳定性和/或减少的免疫原性。
  • Stereoselective synthesis of 4′-selenonucleosides using the Pummerer glycosylation reaction
    作者:Kumarasamy Jayakanthan、Blair D. Johnston、B. Mario Pinto
    DOI:10.1016/j.carres.2008.02.014
    日期:2008.7
    The syntheses of four selenonucleosides, namely 4 '-O-selenoadenosine, -cytidine, -thymidine, and -uridine are described. Commercially available D-ribonolactone was converted to the key intermediate 1,4-anhydro-4-seleno-D-ribitol in seven steps in overall excellent yield. Oxidation of the seleno-D-ribitol with MCPBA gave a single diastereomeric selenoxide in excellent yield, which upon Pummerer reaction in the presence of silylated purine or pyrimidine bases gave stereoselectively the corresponding 4'-beta-selenonucleosides. The stereochemistry at the anomeric center was determined by means of 1D-NOE experiments. (C) 2008 Elsevier Ltd. All rights reserved.
查看更多